BNT211 / BioNTech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BNT211 / BioNTech
CARVac, NCT04503278 / 2019-004323-20: A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Recruiting
1
145
Europe, RoW
CLDN6 CAR-T, CLDN6 uRNA-LPX/CLDN6 modRNA-LPX
BioNTech Cell & Gene Therapies GmbH
Solid Tumor
01/27
01/40

Download Options